WuXi XDC (2268 HK)

179

Analysis

Industrials • China

WuXi XDC is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in antibody-drug conjugates (ADCs) and other bioconjugates. The company offers integrated, end-to-end services for the discovery, process development, and GMP manufacturing of bioconjugates, monoclonal antibody intermediates, and payload-linkers. WuXi XDC was founded in 2013 and is headquartered in Wuxi, China.

Refresh

Exchange Announcement • 18 Sep 2026 17:25

Interim Report 2026

Exchange Announcement • 28 Aug 2026 21:11

Next Day Disclosure Return

Exchange Announcement • 25 Aug 2026 21:55

Grant Of Restricted Shares Under The 2024 Share Scheme

Exchange Announcement • 24 Aug 2026 19:24

Inside Information 2026 Interim Results Presentation

Exchange Announcement • 24 Aug 2026 19:21

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Interim Report 2026

Next Day Disclosure Return

Grant Of Restricted Shares Under The 2024 Share Scheme

Inside Information 2026 Interim Results Presentation

Interim Results Announcement For The Six Months Ended June 30, 2026